Esperion Therapeutics Inc (ESPR) — Free Cash Flow Generation Index
Latest as of March 2024:
1.00x
Esperion Therapeutics Inc (ESPR) has a Free Cash Flow Generation Index of 1.00x as of March 2024. Free cash flow of $53.76 Million represents 1% of operating cash flow ($53.83 Million). See ESPR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$53.76 Million
USD
Operating Cash Flow
$53.83 Million
USD
Capital Expenditures
$73.00K
USD
Annual Free Cash Flow Generation for Esperion Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Esperion Therapeutics Inc. For the full company profile including market capitalisation, see Esperion Therapeutics Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).